CELESTINE TUNG to Biomarkers, Tumor
This is a "connection" page, showing publications CELESTINE TUNG has written about Biomarkers, Tumor.
Connection Strength
0.203
-
Biomarker discovery in ovarian cancer. Womens Health (Lond). 2008 Jan; 4:27-40.
Score: 0.169
-
Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer. Gynecol Oncol. 2017 10; 147(1):41-46.
Score: 0.021
-
The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. Am J Surg Pathol. 2011 Jun; 35(6):904-12.
Score: 0.013